ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $410,000 | +14.8% | 100,000 | 0.0% | 0.00% | – |
| Q4 2021 | $357,000 | -1.9% | 100,000 | 0.0% | 0.00% | – |
| Q3 2021 | $364,000 | -16.5% | 100,000 | 0.0% | 0.00% | – |
| Q2 2021 | $436,000 | +6.1% | 100,000 | 0.0% | 0.00% | – |
| Q1 2021 | $411,000 | +3.0% | 100,000 | 0.0% | 0.00% | – |
| Q4 2020 | $399,000 | +47.8% | 100,000 | 0.0% | 0.00% | – |
| Q3 2020 | $270,000 | -1.8% | 100,000 | 0.0% | 0.00% | – |
| Q2 2020 | $275,000 | +16.5% | 100,000 | 0.0% | 0.00% | – |
| Q1 2020 | $236,000 | -49.9% | 100,000 | -0.3% | 0.00% | – |
| Q4 2019 | $471,000 | +10.6% | 100,262 | -21.1% | 0.00% | – |
| Q3 2019 | $426,000 | -12.9% | 127,086 | -14.5% | 0.00% | – |
| Q2 2019 | $489,000 | +1.7% | 148,656 | -6.3% | 0.00% | – |
| Q1 2019 | $481,000 | -20.4% | 158,594 | -28.6% | 0.00% | -100.0% |
| Q4 2018 | $604,000 | +79.8% | 222,039 | +122.0% | 0.00% | – |
| Q3 2018 | $336,000 | +30.2% | 100,000 | 0.0% | 0.00% | – |
| Q2 2018 | $258,000 | +17.3% | 100,000 | 0.0% | 0.00% | – |
| Q1 2018 | $220,000 | +10.6% | 100,000 | 0.0% | 0.00% | – |
| Q4 2017 | $199,000 | -38.6% | 100,000 | 0.0% | 0.00% | – |
| Q3 2017 | $324,000 | +0.6% | 100,000 | 0.0% | 0.00% | – |
| Q2 2017 | $322,000 | +13.4% | 100,000 | 0.0% | 0.00% | – |
| Q1 2017 | $284,000 | +21.9% | 100,000 | 0.0% | 0.00% | – |
| Q4 2016 | $233,000 | +23200.0% | 100,000 | +14714.8% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 675 | -3.8% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 702 | +3.5% | 0.00% | – |
| Q4 2015 | $1,000 | -80.0% | 678 | -74.7% | 0.00% | – |
| Q3 2015 | $5,000 | 0.0% | 2,678 | +0.9% | 0.00% | – |
| Q2 2015 | $5,000 | -28.6% | 2,655 | +11.7% | 0.00% | – |
| Q1 2015 | $7,000 | 0.0% | 2,376 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | 0.0% | 2,376 | -29.6% | 0.00% | – |
| Q3 2014 | $7,000 | -87.5% | 3,376 | -83.6% | 0.00% | – |
| Q2 2014 | $56,000 | -23.3% | 20,576 | 0.0% | 0.00% | – |
| Q1 2014 | $73,000 | -42.1% | 20,576 | -27.0% | 0.00% | – |
| Q4 2013 | $126,000 | +18.9% | 28,200 | +7.6% | 0.00% | – |
| Q3 2013 | $106,000 | +71.0% | 26,200 | +74.7% | 0.00% | – |
| Q2 2013 | $62,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |